INNOVA CAPTAB
|
The Current P/S Ratio of INNOVA CAPTAB is 3.28.
| Share Price | ₹1,003.2 | Nov 03,2026 |
| Market Cap | ₹5,738.3 Cr | |
| Sales-TTM | ₹1,749.3 Cr | TTM-Consolidated Results |
| Price/Sales | 3.28x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of INNOVA CAPTAB
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹5,738.3 Cr] as on Nov 03,2026
(/) Sales [ ₹1,749.3 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 3.28x ]
Thus, for INNOVA CAPTAB , the investors are currently willing to pay '3.28 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of INNOVA CAPTAB !
The chart below summarizes the trend in P/S Ratio of INNOVA CAPTAB over the last five years.
Historical PS (Price/Sales) ratio chart of INNOVA CAPTAB
PS Ratio Performance Analysis for INNOVA CAPTAB
- INNOVA CAPTAB 's p/e ratio for fiscal years ending Mar2026 to Mar2022 averaged 1.76x.
- INNOVA CAPTAB 's operated at median p/e ratio of 2.37x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, INNOVA CAPTAB 's p/e ratio peaked in Mar2025 at 4.04x.
- INNOVA CAPTAB 's p/e ratio hit its five-year low in Mar2023 of 0x.
How does INNOVA CAPTAB 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| INNOVA CAPTAB | 1,749.3 | 3.28 | 5,738.3 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 61,630.9 | 6.90 | 425,150.0 |
| DIVIS LABORATORIES LTD | 11,230.0 | 23.71 | 266,265.0 |
| TORRENT PHARMACEUTICALS LTD | 17,400.0 | 10.13 | 176,300.0 |
| CIPLA LTD | 28,138.9 | 4.00 | 112,474.0 |
| DR REDDYS LABORATORIES LTD | 33,097.4 | 3.45 | 114,351.0 |
| MANKIND PHARMA LTD | 15,378.6 | 6.65 | 102,315.0 |
| LUPIN LTD | 29,966.6 | 3.07 | 92,007.4 |
| ZYDUS LIFESCIENCES LTD | 28,591.7 | 4.32 | 123,591.0 |
| AUROBINDO PHARMA LTD | 34,935.3 | 2.80 | 97,756.7 |
| LAURUS LABS LTD | 7,822.5 | 16.02 | 125,352.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs INNOVA CAPTAB 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.80x |
| Max industry PS | 23.71x |
| Median industry PS | 4.32x |
| Average industry PS | 7.67x |
You may also like the below Video Courses